Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,730,000 | 1,283,000 | 482,000 | 492,000 | 568,000 |
| Marketable Securities | 829,000 | 2,309,000 | 68,000 | 68,000 | 1,612,000 |
| Inventories | 2,400,000 | 2,277,000 | 2,333,000 | 2,345,000 | 2,306,000 |
| Other current assets | 6,196,000 | 5,201,000 | 7,585,000 | 7,021,000 | 4,707,000 |
| TOTAL | $11,155,000 | $11,268,000 | $10,468,000 | $9,926,000 | $9,193,000 |
| Non-Current Assets | |||||
| PPE Net | 6,849,000 | 6,642,000 | 6,628,000 | 6,597,000 | 6,393,000 |
| Intangibles | 1,818,000 | 1,136,000 | 1,161,000 | 1,162,000 | 1,126,000 |
| Other Non-Current Assets | 2,673,000 | 2,544,000 | 2,424,000 | 2,439,000 | 2,602,000 |
| TOTAL | $11,340,000 | $10,322,000 | $10,213,000 | $10,198,000 | $10,121,000 |
| Total Assets | $22,495,000 | $21,590,000 | $20,681,000 | $20,124,000 | $19,314,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,353,000 | 2,281,000 | 3,050,000 | 3,100,000 | 3,018,000 |
| Accounts payable and accrued liabilities | 7,265,000 | 812,000 | 5,687,000 | 5,593,000 | 5,312,000 |
| TOTAL | $9,618,000 | $9,084,000 | $8,737,000 | $8,693,000 | $8,330,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,636,000 | 1,751,000 | 1,978,000 | 1,953,000 | 1,888,000 |
| Other Non-Current Liabilities | 1,791,000 | 556,000 | 608,000 | 721,000 | 798,000 |
| TOTAL | $4,225,000 | $3,551,000 | $3,821,000 | $3,870,000 | $3,801,000 |
| Total Liabilities | $13,843,000 | $12,635,000 | $12,558,000 | $12,563,000 | $12,131,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,558,000 | 1,556,000 | 1,555,000 | 1,552,000 | 1,551,000 |
| Retained earnings | 4,374,000 | 4,276,000 | N/A | N/A | N/A |
| Other shareholders' equity | 1,849,000 | 1,849,000 | 5,333,000 | 4,813,000 | 4,517,000 |
| TOTAL | $7,854,000 | $7,711,000 | $6,888,000 | $6,365,000 | $6,068,000 |
| Total Liabilities And Equity | $21,697,000 | $20,346,000 | $19,446,000 | $18,928,000 | $18,199,000 |